Raquel Ibanez-Aguiar
Kirkland, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical Model.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: April 10, 2026
Impact of early-stage immunotherapy on health and work productivity in the Czech Republic, 2024-2033.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: February 24, 2026
Assessing the health outcomes, productivity gains, and budget impact of anti-PD-(L)1's in the early stages of cancer treatment in Greece.
Journal: Frontiers in oncology
Published: February 20, 2026
Health and productivity benefits of anti-PD-(L)1 agents for early-stage cancer treatment in Hungary.
Health and productivity benefits of anti-PD-(L)1 agents for early-stage cancer treatment in Hungary.
Journal: Journal of medical economics
Published: February 18, 2026
Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access.
Journal: Journal of medical economics
Published: February 07, 2026
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.
Journal: Clinical drug investigation
Published: December 09, 2025
The Health Impact of Using Anti-PD-1 Agents to Treat Early-Stage Cancer in Belgium.
Journal: Oncology and therapy
Published: May 13, 2025
Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus study.
Journal: Journal for immunotherapy of cancer
Published: May 09, 2025
Impact on health outcomes and productive work of adding anti-PD-1 agents to treat early-stage cancers in the United Kingdom: a modelling study.
Journal: Frontiers in pharmacology
Published: April 23, 2025
Systematic literature review of real-world evidence on overall survival in cancer patients before and after the approval of anti-PD-(L)1 therapy.
Journal: Frontiers in oncology
Published: April 21, 2025
Early detection of non-small cell lung cancer: an electronic health record data-driven approach.
Journal: BMC medicine
Published: April 12, 2025
Health impact of using anti-PD-(L)1 agents to treat early-stage cancers in Switzerland: a modeling study.
Journal: Frontiers in immunology
Published: March 28, 2025
Last Updated: 09/26/2026